Phase 1 Malignant Solid Tumour Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
A Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Initial Efficacy of JS212 in Subjects With Advanced Malignant Solid Tumour
Advanced Malignant Solid Tumours
Shanghai Junshi Bioscience Co., Ltd.374 enrolled1 locationNCT06888830
Recruiting
Phase 1Phase 2
Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB41 in Adult Patients with Advanced Malignant Solid Tumours.
Advanced Malignant Solid Tumours
Sinocelltech Ltd.441 enrolled1 locationNCT06600022
Not Yet Recruiting
Phase 1
A First-in-Human Study to Evaluate the Administration of ReoCure alone and in combination with Keytruda (Pembrolizumab) in Patients with Advanced Malignant Solid Tumours
Advanced Malignant Solid Tumours
ViroCure, Inc.45 enrolled3 locationsACTRN12620000777998
Terminated
Phase 1
An open-label, single-centre Phase I study of the safety and tolerability of PG545 in patients with advanced solid tumours
Non hematologic, malignant solid tumours, excluding primary brain or spinal tumours.
Progen Pharmaceuticals Ltd25 enrolled1 locationACTRN12611000016932